Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study to Analyze a Metabolomic Profile and to Explore it as Prognostic Factor in Patients With Renal Cell Carcinoma (mRCC)

NCT02001493 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT02001493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02001493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study to Analyze a Metabolomic Profile and to Explore it as Prognostic Factor in Patients With Renal Cell Carcinoma (mRCC)
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2015
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma